SMTL ID : 9fci.1

USP1 bound to KSQ-4279 and ubiquitin conjugated to FANCD2 (focused refinement)

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-mer

Ligands

1 x ZN: ZINC ION

ZN.1: 4 residues within 4Å: Chain A: C.441, C.444, C.507, C.510 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.441, A:C.444, A:C.507, A:C.510

1 x 01: 6-(4-cyclopropyl-6-methoxy-pyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine

01.2: 14 residues within 4Å: Chain A: L.97, Q.98, Y.101, F.102, V.157, Q.161, P.179, V.601, L.749, F.751, D.753, S.754, V.756, V.758 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.97, A:Q.161, A:P.179, A:L.749, A:F.751, A:V.756, A:V.756, A:V.758 Hydrogen bonds: A:Q.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rennie, M.L. et al., Structural and Biochemical Insights into the Mechanism of Action of the Clinical USP1 Inhibitor, KSQ-4279. J.Med.Chem. (2024)

Release Date

2024-09-04

Peptides

Ubiquitin carboxyl-terminal hydrolase 1: A
Polyubiquitin-C: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

B
C

Ubiquitin carboxyl-terminal hydrolase 1

Polyubiquitin-C

Related Entries With Identical Sequence